{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.",
    "Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland."
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 15,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Rachel Ershler"
    },
    {
      "affs": [
        0
      ],
      "name": "Xueping Zhou"
    },
    {
      "affs": [
        0
      ],
      "name": "Keng Hee Peh"
    },
    {
      "affs": [
        0
      ],
      "name": "Hui Wei"
    },
    {
      "affs": [
        0
      ],
      "name": "Somak Chatterjee"
    },
    {
      "affs": [
        0
      ],
      "name": "Xiling Jiang"
    },
    {
      "affs": [
        0
      ],
      "name": "Jiang Liu"
    },
    {
      "affs": [
        0
      ],
      "name": "Olanrewaju O. Okusanya"
    },
    {
      "affs": [
        0
      ],
      "name": "Yuan-Li Shen"
    },
    {
      "affs": [
        0
      ],
      "name": "Natasha Kormanik"
    },
    {
      "affs": [
        0
      ],
      "name": "Theresa Carioti"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "R. Angelo de Claro"
    },
    {
      "affs": [
        0
      ],
      "name": "Bindu Kanapuru"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Nicole J. Gormley"
    },
    {
      "affs": [
        0
      ],
      "name": "Yvette L. Kasamon"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/a9cc2rwcj2hxq.bib",
  "cited_by": 0,
  "doi": "10.1158/1078-0432.ccr-26-1867",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13713113/",
  "id": "a9cc2rwcj2hxq",
  "issns": [
    "1078-0432",
    "1557-3265"
  ],
  "landing_url": "https://doi.org/10.1158/1078-0432.ccr-26-1867",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Article"
    ],
    [
      "openalex",
      "2734|Lymphoma Diagnosis and Treatment"
    ]
  ],
  "openalex": "W7215127743",
  "pdf_url": null,
  "pmcid": "PMC13713113",
  "pmid": "42820870",
  "published": "2026-10-01",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/a9cc2rwcj2hxq.ris",
  "sources": [
    {
      "first_seen": "2026-10-31T12:23:32Z",
      "native_id": "PMC13713113",
      "source": "pmc",
      "url": "https://doi.org/10.1158/1078-0432.ccr-26-1867"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2734|Lymphoma Diagnosis and Treatment",
      "subfield": "general"
    }
  ],
  "title": "FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma",
  "title_text": "FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma",
  "type": "peer-reviewed",
  "updated_at": "2026-10-31T12:23:32Z",
  "url": "https://research.draconitic.com/paper/a9cc2rwcj2hxq",
  "venue": "Clinical cancer research : an official journal of the American Association for Cancer Research",
  "versions": []
}